Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
NCT02715973 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-12-06
Summary
Children (Exclusively breast fed: 6mo - 3yrs, and who are not exclusively breast fed 3mo to 3 yrs) with infantile cholestasis syndrome will be randomized to either recieve indigenously prepared oral nutritional supplement (energy dense supplement appox. 2 kcal/mL, prepared from locally available, affordable, socially acceptable food items - milk, sugar, edible coconut oil, egg and custard powder as base) in addition to standard nutritional counseling by a trained dietician (Group A). The control group (Group B) in comparison will receive standard nutritional counseling from a trained dietician but will not receive any additional nutritional supplement. All the children will be followed up at 1 month, 3 months, 6 months, 9 months and 1 year after inclusion. Clinical, nutritional assessment and laboratory data will be collected at each visit. Additionally IL-6 levels will be done at each visit in children of both arms of the intervention group.
The outcomes of interest will be growth and improvement of nutritional status parameters, hepatic morbidity (ascites, gastrointestinal bleeding, encephalopathy, {SBP (Spontaneous Bacterial Peritonitis), HRS (Hepatorenal Syndrome), etc and outcome (improvement, death or Liver Transplantation}.
All children will receive individualized standard treatment for infantile cholestasis syndrome including vitamin supplements/endotherapy/ beta blockers/ prophylaxis for SBP (Spontaneous Bacterial Peritonitis)/cholangitis (to at risk children) and drug therapy wherever indicated (steroids/ copper chelation/ UDCA).
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Nutritional Supplement
Energy dense supplement appox. 2 kcal/mL, prepared from locally available, affordable, socially acceptable food items - milk, sugar, edible coconut oil, egg and custard powder as base) in addition to standard nutritional counseling by a trained dietician as per the recommended daily allowance according to gender and age.
- DIETARY_SUPPLEMENT
-
Standard Nutritional Treatment
Standard nutritional counseling by a trained dietician as per the recommended daily allowance according to gender and age
Sponsors & Collaborators
-
Institute of Liver and Biliary Sciences, India
lead OTHER
Principal Investigators
-
Dr Seema Alam, MD · Institute of Liver and Biliary Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Months
- Max Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-01
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-31
Countries
- India
Study Locations
More Related Trials
-
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
NCT04542473 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Compassionate Use of Omegaven in Children
NCT02370251 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
NCT01739517 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Oral Nutrition in Mild Acute Pediatric Pancreatitis
NCT01423786 ·Status: TERMINATED ·Phase: NA
-
Cholestasis Prevention: Efficacy of IV Fish Oil
NCT00512629 ·Status: COMPLETED ·Phase: PHASE1
-
Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis
NCT05043194 ·Status: UNKNOWN ·Phase: NA
-
Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
NCT01191177 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4
-
Curcumin for Pediatric Nonalcoholic Fatty Liver Disease
NCT04109742 ·Status: WITHDRAWN ·Phase: PHASE2
-
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523 ·Status: COMPLETED ·Phase: PHASE3
-
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
NCT01934777 ·Status: COMPLETED ·Phase: PHASE3
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
NCT01974336 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
NCT01555957 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT06133101 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
NCT00004368 ·Status: UNKNOWN ·Phase: PHASE1
-
Total Parenteral Nutrition-Associated Liver Disease
NCT00031135 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
NCT00004315 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Lactulose in Children With Chronic Liver Disease
NCT00811434 ·Status: TERMINATED ·Phase: PHASE2
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children
NCT01194063 ·Status: COMPLETED ·Phase: PHASE3